Medicinal Products

Loquen XR 50 mg tablete s produljenim oslobađanjem

Name Loquen XR 50 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-441303743
Active Substance quetiapinum
Pharmaceutical Form tableta s produljenim oslobađanjem
Strength 50 mg
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-441303743-01]
20 tableta u blisteru, u kutiji  [HR-H-441303743-02]
30 tableta u blisteru, u kutiji  [HR-H-441303743-03]
50 tableta u blisteru, u kutiji  [HR-H-441303743-04]
50 tableta u u blisteru s jediničnom dozom, u kutiji  [HR-H-441303743-05]
56 tableta u blisteru, u kutiji  [HR-H-441303743-06]
60 tableta u blisteru, u kutiji  [HR-H-441303743-07]
90 tableta u blisteru, u kutiji  [HR-H-441303743-08]
100 tableta u blisteru, u kutiji  [HR-H-441303743-09]
60 tableta u bočici, u kutiji  [HR-H-441303743-10]
Manufacturer Teva Gyogyszergyar Zrt., Debrecen, Mađarska
Pharmachemie B.V., Haarlem, Nizozemska
Teva Czech Industries s.r.o., Opava-Komarov, Češka
Teva Operations Poland Sp. z o.o., Krakow, Poljska
Teva Pharma S.L.U., Zaragoza, Španjolska
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Adamed Sp. z o.o., Czosnow, Poljska
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date 08.05.2019
MA Period of Validity unlimited
Classification Number UP/I-530-09/18-02/161
Registration Number 381-12-01/38-19-04
Composition svaka tableta sadrži 50 mg kvetiapina u obliku kvetiapinfumarata
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N05AH04
Medicinal product marketed in the Croatia Trajni prekid opskrbe
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2
Back